Is Harvard Bioscience, Inc. (NASDAQ:HBIO) Expensive At $4.5? Here's How To Know.

Retrieved on: 2020-12-19 21:00:00

Tags for this article:

Financial markets

Finance

Initial public offering

Initial public offering of Facebook

Price?earnings ratio

Harvard Bioscience Inc.

Click the tags to see associated articles and topics

Is Harvard Bioscience, Inc. (NASDAQ:HBIO) Expensive At $4.5? Here's How To Know.. View article details on hiswai:

Excerpt

Blackrock Inc. is the top institutional holder at HBIO for having 2.8 Million shares of worth $8.44 Million. And as of September 29, 2020, it was holding ...

Article found on: marketingsentinel.com

View Original Article